Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

Long-term Safety Study of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia Who Completed a Previous ORX750 Trial

Recruiting

2 1 1
Investigated diseases:
- Narcolepsy
Investigated drugs:
- ORX750
A Study to Test the Safety and Effectiveness of TAK-360 in People with Narcolepsy without Cataplexy

Recruiting

2 1
Investigated diseases:
- Narcolepsy
Study on the Safety and Effects of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia

Recruiting

2 1
Investigated diseases:
- Narcolepsy
Investigated drugs:
- ORX750
Long-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2

Recruiting

4 1 1
Investigated diseases:
- Narcolepsy
Investigated drugs:
- Alks 2680
Study on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1

Recruiting

4 1
Investigated diseases:
- Narcolepsy
Investigated drugs:
- N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
+5
Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

Not yet recruiting

3 1
Investigated drugs:
- Alks 2680
Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

Not yet recruiting

3 1
Investigated drugs:
- Alks 2680
Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Not yet recruiting

3 1
Investigated diseases:
- Narcolepsy
Investigated drugs:
- N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
+5
Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Not recruiting

3 1
Investigated diseases:
- Narcolepsy
Investigated drugs:
- N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
A study testing the safety and how the body processes TAK-861 in children and teenagers aged 6 to 17 years with narcolepsy type 1

Not recruiting

1 1 1
Investigated diseases:
- Narcolepsy
Investigated drugs:
- N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide

Find clinical trials in your area

Matched clinical trials

We use cookies